Patch Test Products and Reference Manual 2015

Total Page:16

File Type:pdf, Size:1020Kb

Patch Test Products and Reference Manual 2015 PATCH TEST PRODUCTS & REFERENCE MANUAL MANUAL REFERENCE & PRODUCTS TEST PATCH 4 World Leader in Patch Testing 2015 CHEMOTECHNIQUE DIAGNOSTICS CHEMOTECHNIQUE PATCH TEST PRODUCTS & REFERENCE MANUAL 2015 MODEMGATAN 9 | SE-235 39 VELLINGE |SWEDEN PHONE +46 40 466 077 | FAX +46 40 466 700 WWW.CHEMOTECHNIQUE.SE [email protected] | [email protected] ...for the diagnosis of contact allergy 2015 The complete range of products for Patch Testing A1 Foreword by Bo Niklasson, CEO First of all I would like to thank all our faithful customers for your support during the past year and also welcome our new distributors that have been appointed during the year. Chemotechnique Diagnostic’s 34 years of continuous growth and development has been the result of our belief in building strong and long term business relationships with our global network of distributors, combined with the ongoing support and contributions of our product-user base of physicians. Our commitment is to continue serving dermatology in future years... maintaining our leadership position. During the past year we have invested in new state of the art equipment in both the analytical and production sector and developed a closed loop system in the production of haptens. When looking at our website you will note that we have made it possible also for patients to freely access our database of extensive information regarding the haptens and being able to print information sheets. We have also changed the site to be adapted to mobile platforms such as mobile phones, iPads and similar devices. There will as always be additions and amendments in our range and these are found at the end of the Patch Test Products & Reference Manual. At Chemotechnique Diagnostics, our passion and total focus on contact dermatitis and patch testing is to ensure that you, as a physician, will have the most advanced products and services that will provide your patients with improved health and enhanced quality of life. We look forward to continuing to serve you in 2015. A2 ...for the diagnosis of contact allergy Chemotechnique Diagnostics Chemotechnique Diagnostics is recognized as the world´s leading patch test company with the widest global distribution network and product range, with more than 550 different haptens distributed in about 90 countries around the world. Countries (in blue) where Chemotechnique Diagnostics has distributors. We offer the most complete range of high quality products including haptens (allergens) and test chambers for patch testing in the diagnosis of contact dermatitis. The contamination free haptens are produced under strict pharmaceutical control following the GMP quality management system audited by the Swedish Medical Products Agency (MPA). In addition, our whole operation follows the ISO 13485 and ISO 9001 Quality Management systems. Our products will therefore enable you to perform a valid diagnosis of contact allergy in your patients. We focus on Research and Development (R & D) to produce new and relevant haptens for patch testing as well as new products in the medical device sector with special emphasis in the field of occupational dermatology. By cooperating with national contact dermatitis associations in various countries we want to meet the needs of specific regions. We are guided by contact dermatitis groups such as the International Contact Dermatitis Research Group (ICDRG), European Environmental and Contact Dermatitis Research Group (EECDRG) and North American Contact Dermatitis Group (NACDG). With this in mind we believe ourselves to be up to date and able to facilitate dermatological investigations where patch tests are involved. For example, in 2013 Chemotechnique Diagnostics co-authored an article in Contact Dermatitis in cooperation with the University of Gothenburg. A3 Patch Test Products authorized by the ICDRG Distributed Worldwide Customer service: Enrico, Sara, Katarina, Marie, Anna and Therese Production: Chemotechnique Diagnostics Printing: Tryckfolket 2015 Revised: January 2015 Copyright : Chemotechnique Diagnostics AB DISTRIBUTOR A4 ...for the diagnosis of contact allergy Table of Contents Content Page Foreword by Bo Niklasson, CEO ............................................................... A2 Chemotechnique Diagnostics .................................................................. A3 General information ...................................................................................... 4 FAQ ................................................................................................................... 5 Products .......................................................................................................... 6 Patch Testing - Instructions for IQ Ultra™ ................................................ 20 Photopatch testing (PPT) - ......................................................................... 24 Patch Test Hapten Series ............................................................................ 28 Table of Mixes ............................................................................................... 67 Article Guide to Haptens ............................................................................ 74 Table of Haptens .......................................................................................... 91 Catalogue amendments January 2015 .................................................215 References for IQ Chambers™ & IQ Ultra™ ............................................216 Ordering procedure ..................................................................................219 Conditions of Sale ......................................................................................219 1 www.chemotechnique.se Welcome to the new version of our website! When you visit the webpage for the first time you will get an option to choose between the Physician section or the Patient section. The Physician section provides access to the full extent of the website following log in. The Patient section is without log in and is limited to give basic information about contact dermatitis and gives the ability to print information about all our haptens (allergens). Patient section Physician section The website is adapted to fit all mobile platforms such as smartphones and tablets. Tablet version Smartphone version 2 ...the trusted name in patch testing Downloadable content at www.chemotechnique.se Patient information sheets are available for each hapten, explaining where the substance can be found and if there are some known synonyms of the substance. Below is an example of a Patient Information Sheet, available in English, French, Spanish, and selected series in Swedish. Material Safety Data Sheets are available in English for all the haptens. Patch test record forms for all series are available. Download here to get the latest composition for each series. PATIENT INFORMATION SHEET Nickel(II)sulfate hexahydrate (N-002A, N-002B) Your patch testing results indicate that you have a contact allergy to Nickel(II)sulfate hexahydrate. It is important that you familiarize yourself with this chemical and take steps to avoid coming in contact with it. What is Nickel(II)sulfate hexahydrate and where is it found? This chemical has numerous household and industrial applications. It is found in coins, jewelry, eyeglasses, utensils, metal buttons, keys, paper clips, enamel dyes, pigment for paint and wallpaper and electrical wiring. It is also used as a fuel additive. Further research may identify additional product or industrial usages of this chemical. What else is Nickel(II)sulfate hexahydrate called? This chemical can be identified by different names, including: Blue salt, Carbonyl nickel powder, Nickel, Nickel (II) Sulfate Hexahydrate, Nickel monosulfate hexahydrate, Nickel sulfate hexahydrate, Sulfuric acid, nickel (2+) salt, hexahydrate, Single nickel salt This may not be a complete list as manufacturers introduce and delete chemicals from their product lines. THINGS YOU CAN DO TO HELP MANAGE YOUR CONTACT ALLERGY Be vigilant... read the product label. Always take the time to read the ingredient listing on product packages. This should be your first step each time you purchase a product as manufacturers sometimes change product ingredients. If you have any concerns ask your pharmacist or your doctor. Test the product first. If you have purchased a new product you should test it on a small skin area to see if you get a reaction before using the product on larger skin areas. Advise people you obtain services from of your contact allergy. This should include people like your pharmacist, doctor, hairdresser, florist, veterinarian, etc. Inform your employer if the source of your contact allergy is work related. You should identify the specific source of the chemical and take the necessary steps to avoid further exposure. Protective wear may be adequate or you may need to make a change in your work activities. Both you and your employer benefit when the cause of your occupational dermatitis is eliminated. To the left: Patient information sheet "Google" it. The internet is an excellent source of ingredient information that can be searched by product, by company and by specific chemical. Some helpful independent internet links include: www.nlm.nih.gov/pubs/factsheets/factsheets.html (U.S. Dept. of Health and Human Services; alphabetic list) www.nlm.nih.gov/pubs/factsheets/factsubj.html (U.S. Dept. of Health and Human Services; subject Bottom left: Material Safety Data list) www.cosmeticsinfo.org (Cosmetic Industry
Recommended publications
  • Antiseptics and Disinfectants for the Treatment Of
    Verstraelen et al. BMC Infectious Diseases 2012, 12:148 http://www.biomedcentral.com/1471-2334/12/148 RESEARCH ARTICLE Open Access Antiseptics and disinfectants for the treatment of bacterial vaginosis: A systematic review Hans Verstraelen1*, Rita Verhelst2, Kristien Roelens1 and Marleen Temmerman1,2 Abstract Background: The study objective was to assess the available data on efficacy and tolerability of antiseptics and disinfectants in treating bacterial vaginosis (BV). Methods: A systematic search was conducted by consulting PubMed (1966-2010), CINAHL (1982-2010), IPA (1970- 2010), and the Cochrane CENTRAL databases. Clinical trials were searched for by the generic names of all antiseptics and disinfectants listed in the Anatomical Therapeutic Chemical (ATC) Classification System under the code D08A. Clinical trials were considered eligible if the efficacy of antiseptics and disinfectants in the treatment of BV was assessed in comparison to placebo or standard antibiotic treatment with metronidazole or clindamycin and if diagnosis of BV relied on standard criteria such as Amsel’s and Nugent’s criteria. Results: A total of 262 articles were found, of which 15 reports on clinical trials were assessed. Of these, four randomised controlled trials (RCTs) were withheld from analysis. Reasons for exclusion were primarily the lack of standard criteria to diagnose BV or to assess cure, and control treatment not involving placebo or standard antibiotic treatment. Risk of bias for the included studies was assessed with the Cochrane Collaboration’s tool for assessing risk of bias. Three studies showed non-inferiority of chlorhexidine and polyhexamethylene biguanide compared to metronidazole or clindamycin. One RCT found that a single vaginal douche with hydrogen peroxide was slightly, though significantly less effective than a single oral dose of metronidazole.
    [Show full text]
  • Research Article Development and Validation of a Stability Indicating
    Hindawi Publishing Corporation ISRN Chromatography Volume 2013, Article ID 506923, 12 pages http://dx.doi.org/10.1155/2013/506923 Research Article Development and Validation of a Stability Indicating RP-HPLC Method for the Determination of Two Sun Protection Factors (Koptrizon and Tinosorb S) in Topical Pharmaceutical Formulations Using Experimental Designs Chinmoy Roy1,2 and Jitamanyu Chakrabarty2 1 Analytical Research and Development, Dr. Reddy’s Laboratories Ltd., Bachupally, Hyderabad, Andhra Pradesh 500090, India 2 Department of Chemistry, National Institute of Technology, Durgapur, West Bengal 713209, India Correspondence should be addressed to Chinmoy Roy; [email protected] Received 11 March 2013; Accepted 15 April 2013 Academic Editors: C. Akbay and J. A. P. Coelho Copyright © 2013 C. Roy and J. Chakrabarty. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. A novel, simple, validated stability indicating HPLC method was developed for determination of Koptrizon and Tinosorb S. Stability indicating power of the method was established by forced degradation study. The chromatographic separation was achieved with Waters X Bridge C18 column, by using mobile phase consisting of a mixture of acetonitrile : tetrahydrofuran : water (38 : 38 : 24, v/v/v). The method fulfilled validation criteria and was shown to be sensitive, with limits of detection (LOD) and quantitation −1 −1 (LOQ) of 0.024 and 0.08 gmL for Koptrizon and 0.048 and 0.16 gmL for Tinosorb S, respectively. The developed method is validated for parameters like precision, accuracy, linearity, solution stability, specificity, and ruggedness as per ICH norms.
    [Show full text]
  • Quaternary Ammonium Compounds
    FACT SHEET: Quaternary Ammonium Compounds Quaternary ammonium compounds, also known as “quats” or “QACs,” include a number of chemicals used as sanitizers and disinfectants, including benzalkonium chloride, benzethonium chloride, cetalkonium chloride, cetrimide, cetrimonium bromide, cetylpyridinium chloride, glycidyl trimethyl, ammonium chloride, and stearalkonium chloride.[i] In general, quats cause toxic effects through all Mutagenicity routes of exposure including inhalation, Some quats have shown to be mutagenic and to ingestion, dermal application, and irrigation of damage animal DNA and DNA in human body cavities. Exposure to diluted solutions may lymphocytes at much lower levels than are result in mild irritation, while concentrated present in cleaning chemicals.[6] solutions are corrosive, causing burns to the skin and mucous Membranes. They can produce Antimicrobial Resistance systemic toxicity and can also cause allergic Genes have been discovered that mediate reactions.[2] resistance to quats. There has been an association of some of these genes with beta lactamase genes, Asthma and Allergies raising concern for a relationship between Of particular interest with regard to use as disinfectant resistance and antibiotic resistance.[7] disinfectants in the COVID-19 pandemic, quats increase the risk for asthma and allergic Reproductive Toxicity sensitization. Evidence from occupational Mice whose cages were cleaned with QACs had exposures shows increased risk of rhinitis and very low fertility rates. [8] Exposure to a common asthma
    [Show full text]
  • Effect of 10 UV Filters on the Brine Shrimp Artemia Salina and the Marine Microalgae Tetraselmis Sp
    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.30.926451; this version posted January 31, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Effect of 10 UV filters on the brine shrimp Artemia salina and the marine microalgae Tetraselmis sp. Evane Thorel, Fanny Clergeaud, Lucie Jaugeon, Alice M. S. Rodrigues, Julie Lucas, Didier Stien, Philippe Lebaron* Sorbonne Université, CNRS USR3579, Laboratoire de Biodiversité et Biotechnologie Microbienne, LBBM, Observatoire Océanologique, 66650, Banyuls-sur-mer, France. *corresponding author : E-mail address : [email protected] Abstract The presence of pharmaceutical and personal care products’ (PPCPs) residues in the aquatic environment is an emerging issue due to their uncontrolled release, through grey water, and accumulation in the environment that may affect living organisms, ecosystems and public health. The aim of this study is to assess the toxicity of benzophenone-3 (BP-3), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), butyl methoxydibenzoylmethane (BM), methylene bis- benzotriazolyl tetramethylbutylphenol (MBBT), 2-Ethylhexyl salicylate (ES), diethylaminohydroxybenzoyl hexyl benzoate (DHHB), diethylhexyl butamido triazone (DBT), ethylhexyl triazone (ET), homosalate (HS), and octocrylene (OC) to marine organisms from two major trophic levels including autotrophs (Tetraselmis sp.) and heterotrophs (Artemia salina). In general, EC50 results show that both HS and OC are the most toxic for our tested species, followed by a significant effect of BM on Artemia salina but only at high concentrations (1 mg/L) and then an effect of ES, BP3 and DHHB on the metabolic activity of the microalgae at 100 µg/L.
    [Show full text]
  • ANNEX VI List of Preservatives Allowed for Use in Cosmetic Products
    ANNEX VI List of preservatives allowed for use in cosmetic products ANNEX VI LIST OF PRESERVATIVES WHICH COSMETIC PRODUCTS MAY CONTAIN Preamble 1. Preservatives are substances which may be added to cosmetic products for the primary purpose of inhibiting the development of micro-organisms in such products. 2. The substances marked with the symbol (+) may also be added to cosmetic products in concentration other than those laid down in this ANNEX for other purposes apparent from the presentation of the products, e.g. as deodorants in soaps or as anti-dandruff agents in shampoos. 3. Other substances used in the formulation of cosmetic products may also have anti-microbial properties and thus help in the preservation of the products, as, for instance, many essential oils and some alcohols. These substances are not included in the ANNEX. 4. For the purposes of this list - “Salts” is taken to mean: salts of the cations sodium, potassium, calcium, magnesium, ammonium, and ethanolamines; salts of the anions chloride, bromide, sulphate, acetate. - “Esters” is taken to mean: esters of methyl, ethyl, propyl, isopropyl, butyl, isobutyl, phenyl. 5. All finished products containing formaldehyde or substances in this ANNEX and which release formaldehyde must be labelled with the warning “contains formaldehyde” where the concentration of formaldehyde in the finished product exceeds 0.05%. Revised as per August 2015 ASEAN Cosmetic Documents 1 Annex VI – Part 1 – List of preservatives allowed for use in cosmetic products ANNEX VI – PART 1 LIST OF PRESERVATIVES ALLOWED Reference Substance Maximum authorized Limitations and Conditions of use and Number concentration requirements warnings which must be printed on the label a b c d e 1 Benzoic acid (CAS No.
    [Show full text]
  • Chemical UVR Absorbers
    Chemical UVR Absorbers The names given in bold and used Diisopropyl methyl cinnamate Glyceryl ethyihexanoate dimethoxy- throughout this handbook are those of Empirical formula: cinnamate the International Nomenclature of C 6H22O2 Chemical names. Cosmetic Ingredients. Glyceryl octanoate dimethoxycinnamate; Chemical names: 2-propenoic acid, 3-(4-methoxyphenyl)-, 2-Propenoic acid, 3-12,4bis(1 diester with 1 ,3-dihydroxy-2-(2-ethyl-1 - methylethyphenyl-methyl ester; 2,5- oxohexyl)oxypropane diisopropyl methyl cinnamate _ lsoamyl-para-methoxycinnamate Ethyihexyl methoxycinnamate Empirical formula: Empirical formula: C151-12003 C 8H26O3 Chemical names: Cinnamates Chemical names: Amyl4-methoxycinnamate; isopentyl-4- 2-Ethylhexyl-4-methoxycin nam ate; methoxycinnamate; isopenlyl-para- Cinoxate 2-ethyl-hexyl-para-methoxycinnamate; methoxy-cinnamate; 3-(4-methoxyphenyl)- Empirical formula: para-methoxycinnamic acid, 2-ethylhexyl 2-propenoic acid, isopentyl ester Ci4HieO4 ester; 3-(4-methoxyphenyl)-2-propenoic acid, 2-ethylhexyl ester; octinoxate; octyl Trade names: Chemical names: methoxycinnamate; 2-propenoic acid, 3- Neo Heliopan type E 1000; Solarum AMC 2- Ethoxyothyl-para-methoxyci n nam ate; (4-methoxyphenyl)-2-ethylhexyl ester 2-propenoic acid, 3-(4-methoxyphery- para-A minobenzoic acids (PA BAs) 2-ethoxyethyl ester; 2-ethoxyethyl-4- Trade names: methoxycinnamate AEC Octyl Methoxycinnamate; Escalol Amyl dimethyl FABA 557; Eusolex 2292; Heliosol 3; Empirical formula: Trade names: Jeescreen OMC; Katoscreen OMC; Nec C14H21 NO2 Giv Tan F; Phiasol
    [Show full text]
  • WO 2013/036901 A2 14 March 2013 (14.03.2013) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/036901 A2 14 March 2013 (14.03.2013) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 8/30 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/US2012/054376 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 10 September 2012 (10.09.2012) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (25) Filing Language: English NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, (26) Publication Language: English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (30) Priority Data: ZM, ZW. 61/532,701 9 September 201 1 (09.09.201 1) US (84) Designated States (unless otherwise indicated, for every (71) Applicant (for all designated States except US): UNIVER¬ kind of regional protection available): ARIPO (BW, GH, SITY OF FLORIDA RESEARCH FOUNDATION, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, INC.
    [Show full text]
  • Annex VI, Last Update: 02/08/2021
    File creation date: 03/10/2021 Annex VI, Last update: 22/09/2021 LIST OF UV FILTERS ALLOWED IN COSMETIC PRODUCTS Substance identification Conditions Wording of Reference Maximum conditions of Product Type, concentration Update date number Chemical name / INN / XAN Name of Common Ingredients Glossary CAS Number EC Number Other use and body parts in ready for use warnings preparation 2 N,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl CAMPHOR BENZALKONIUM 52793-97-2 258-190-8 6% 15/10/2010 ) anilinium methyl sulphate METHOSULFATE 3 Benzoic acid, 2-hydroxy-, HOMOSALATE 118-56-9 204-260-8 10% 02/08/2021 3,3,5-trimethylcyclohexyl ester / Homosalate 4 2-Hydroxy-4-methoxybenzophenone / BENZOPHENONE-3 131-57-7 205-031-5 6% Reg (EU) Not more than Contains 02/08/2021 Oxybenzone 2017/238 of 10 0,5 % to protect Benzophenone-3 February 2017- product (1) date of formulation application from September 2017 6 2-Phenylbenzimidazole-5-sulphonic acid and its PHENYLBENZIMIDAZOLE SULFONIC 27503-81-7 248-502-0 8%(as acid) 08/03/2011 potassium, sodium and triethanolamine salts / ACID Ensulizole 7 3,3'-(1,4-Phenylenedimethylene) bis TEREPHTHALYLIDENE DICAMPHOR 92761-26-7 / 410-960-6 / - 10%(as acid) 26/10/2010 (7,7-dimethyl-2-oxobicyclo-[2.2.1] SULFONIC ACID 90457-82-2 hept-1-ylmethanesulfonic acid) and its salts / Ecamsule 8 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl) BUTYL 70356-09-1 274-581-6 5% 15/10/2010 propane-1,3-dione / Avobenzone METHOXYDIBENZOYLMETHANE 9 alpha-(2-Oxoborn-3-ylidene)toluene-4-sulphoni BENZYLIDENE CAMPHOR SULFONIC 56039-58-8 - 6%(as acid)
    [Show full text]
  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
    MTC eHealth DSI [eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01
    [Show full text]
  • Cutaneous Permeation and Penetration of Sunscreens: Formulation Strategies and in Vitro Methods
    cosmetics Review Cutaneous Permeation and Penetration of Sunscreens: Formulation Strategies and In Vitro Methods Silvia Tampucci * ID , Susi Burgalassi ID , Patrizia Chetoni ID and Daniela Monti ID Department of Pharmacy, University of Pisa, 56126 Pisa, Italy; [email protected] (S.B.); [email protected] (P.C.); [email protected] (D.M.) * Correspondence: [email protected] Received: 1 November 2017; Accepted: 7 December 2017; Published: 25 December 2017 Abstract: Sunscreens are the most common products used for skin protection against the harmful effects of ultraviolet radiation. However, as frequent application is recommended, the use of large amount of sunscreens could reflect in possible systemic absorption and since these preparations are often applied on large skin areas, even low penetration rates can cause a significant amount of sunscreen to enter the body. An ideal sunscreen should have a high substantivity and should neither penetrate the viable epidermis, the dermis and the systemic circulation, nor in hair follicle. The research of methods to assess the degree of penetration of solar filters into the skin is nowadays even more important than in the past, due to the widespread use of nanomaterials and the new discoveries in cosmetic formulation technology. In the present paper, different in vitro studies, published in the last five years, have been reviewed, in order to focus the attention on the different methodological approaches employed to effectively assess the skin permeation and retention of sunscreens. Keywords: sunscreens; formulation; in vitro methods; cutaneous permeation; skin penetration 1. Introduction The detrimental effects of human exposure to ultraviolet (UV) radiation have been widely investigated and can be immediate, as in the case of sunburns, or long-term, causing, in most cases, the formation of oxidizing species responsible of photo-aging, immunosuppression and chronic effects such as photo carcinogenicity [1,2].
    [Show full text]
  • How to Overcome the New Challenges in Sun Care
    Thannhausen, Germany, July 31, 2020 Thannhausen, Germany, | Volume 146 Volume | 7+8/20 home care 60 Years Sinner Circle: The Future powered by of Washing and Cleaning 7/8 2020 english How to Overcome the New Challenges skin care Positive Impact of Emulsifiers sun care in Sun Care on End-user Skin Benefits How to Overcome the New Challenges in Sun Care Natural-based 360° Approach for Optimized Formulations Sunscreen Diversity – more Options for Ingredients oral care How Polyurethane Film Formers Can Help A Natural Way to Treat Tooth Sensitivity Reduce the Impact on the Environment M. Sohn, S. Krus, M. Schnyder, S. Acker, M. Petersen-Thiery, S. Pawlowski, B. Herzog SOFW Journal 7+8/20 | Volume 146 | Thannhausen, Germany, July 31, 2020 personalpersonal care care | sun care From the UV filters under scrutiny, the widely used UVB fil- ters Ethylhexyl Methoxycinnamate (EHMC) and Octocrylene (OCR) are heavily discussed due to rising concerns regarding their safety profile for humans and for the environment. In Europe, legally approved UV filters are additionally assessed by the European Chemical Agency (ECHA) within the Regis- tration, Evaluation, Authorization, and Restriction of Chemi- cals (REACh) process, like all other industrial chemicals. Also, in the USA, the Food and Drug Administration (FDA) issued a proposed rule to put into effect a final monograph for over- the-counter sunscreen drug products [2]. In its proposal the © BASF’s Care Creations® FDA describes the conditions under which a sunscreen active is Generally Recognized as Safe and Effective (GRASE) and highlights the safety data gaps and additional required data for each already approved UV filter to be included in catego- How to Overcome the ry I, UV filters with a positive GRASE.
    [Show full text]
  • Vr Meds Ex01 3B 0825S Coding Manual Supplement Page 1
    vr_meds_ex01_3b_0825s Coding Manual Supplement MEDNAME OTHER_CODE ATC_CODE SYSTEM THER_GP PHRM_GP CHEM_GP SODIUM FLUORIDE A12CD01 A01AA01 A A01 A01A A01AA SODIUM MONOFLUOROPHOSPHATE A12CD02 A01AA02 A A01 A01A A01AA HYDROGEN PEROXIDE D08AX01 A01AB02 A A01 A01A A01AB HYDROGEN PEROXIDE S02AA06 A01AB02 A A01 A01A A01AB CHLORHEXIDINE B05CA02 A01AB03 A A01 A01A A01AB CHLORHEXIDINE D08AC02 A01AB03 A A01 A01A A01AB CHLORHEXIDINE D09AA12 A01AB03 A A01 A01A A01AB CHLORHEXIDINE R02AA05 A01AB03 A A01 A01A A01AB CHLORHEXIDINE S01AX09 A01AB03 A A01 A01A A01AB CHLORHEXIDINE S02AA09 A01AB03 A A01 A01A A01AB CHLORHEXIDINE S03AA04 A01AB03 A A01 A01A A01AB AMPHOTERICIN B A07AA07 A01AB04 A A01 A01A A01AB AMPHOTERICIN B G01AA03 A01AB04 A A01 A01A A01AB AMPHOTERICIN B J02AA01 A01AB04 A A01 A01A A01AB POLYNOXYLIN D01AE05 A01AB05 A A01 A01A A01AB OXYQUINOLINE D08AH03 A01AB07 A A01 A01A A01AB OXYQUINOLINE G01AC30 A01AB07 A A01 A01A A01AB OXYQUINOLINE R02AA14 A01AB07 A A01 A01A A01AB NEOMYCIN A07AA01 A01AB08 A A01 A01A A01AB NEOMYCIN B05CA09 A01AB08 A A01 A01A A01AB NEOMYCIN D06AX04 A01AB08 A A01 A01A A01AB NEOMYCIN J01GB05 A01AB08 A A01 A01A A01AB NEOMYCIN R02AB01 A01AB08 A A01 A01A A01AB NEOMYCIN S01AA03 A01AB08 A A01 A01A A01AB NEOMYCIN S02AA07 A01AB08 A A01 A01A A01AB NEOMYCIN S03AA01 A01AB08 A A01 A01A A01AB MICONAZOLE A07AC01 A01AB09 A A01 A01A A01AB MICONAZOLE D01AC02 A01AB09 A A01 A01A A01AB MICONAZOLE G01AF04 A01AB09 A A01 A01A A01AB MICONAZOLE J02AB01 A01AB09 A A01 A01A A01AB MICONAZOLE S02AA13 A01AB09 A A01 A01A A01AB NATAMYCIN A07AA03 A01AB10 A A01
    [Show full text]